Drug reference
l-dopa
Dopamine Precursor · Parkinson's disease treatment
Dopamine PrecursorParkinson's disease treatment
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Readily crosses the blood-brain barrier (BBB) and is converted to dopamine (DA) in the brain. Commonly formulated with a decarboxylase inhibitor to prevent peripheral conversion to DA.
Indications
Parkinson's disease
Side effects
Serious
- Loss of effectiveness with long-term treatment
- L-DOPA–induced dyskinesias
Related guidelines
Ask House about l-dopa
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team